Lafleur, K., Dong, J., Huang, D., Caflisch, A., & Nevado, C. (2013). Optimization of inhibitors of the tyrosine kinase EphB4. 2. Cellular potency improvement and binding mode validation by X-ray crystallography. Journal of Medicinal Chemistry, 56(1), 84-96. https://doi.org/10.1021/jm301187e (Original work published)

Galzitskaya, O., & Caflisch, A. (1999). Solution conformation of phakellistatin 8 investigated by molecular dynamics simulations. Journal of Molecular Graphics and Modelling, 17(1), 19-27. https://doi.org/doi:10.1016/S1093-3263(99)00017-0 (Original work published 1999)

Unzue, A., Dong, J., Lafleur, K., Zhao, H., Frugier, E., Caflisch, A., & Nevado, C. (2014). Pyrrolo[3,2-b]quinoxaline derivatives as types I1/2 and II Eph tyrosine kinase inhibitors: Structure-based design, synthesis, and in vivo validation. Journal of Medicinal Chemistry, 57(15), 6834-6844. https://doi.org/10.1021/jm5009242 (Original work published)